Verywell / Michela Buttignol
What Is Polycythemia Vera?
Experts recommend that people with PV do not skip appointments if they require phlebotomytreatmentsto control the condition.
People with PV that has progressed tomyelofibrosismay have a higher risk of COVID-19 complications.
Verywell / Michela Buttignol
Data indicates there is variability in the immune response to the vaccines in this population.
The study authors note larger systematic reviews of COVID-19 vaccine adverse effects and outcomes are needed.
Although rare, adverse hematologic events have been reported after COVID-19 mRNA vaccination.
However, none of these adverse events have included PV.
Experts recommend getting the vaccine even if you have a condition such as polycythemia vera.
However, research regarding the effects and effectiveness of COVID vaccines in people with blood disorders is ongoing.
Discuss this with your healthcare provider.
However, this delay is not absolutely necessary.
If you have concerns or questions about getting a COVID vaccine, talk to your healthcare team.
They can advise you about what is best for your health.
The information in this article is current as of the date listed.
As new research becomes available, well update this article.
For the latest on COVID-19, visit ourcoronavirus news page.
Centers for Disease Control and Prevention.Underlying conditions and the higher risk for severe COVID-19.
Johns Hopkins Medicine.Polycythemia vera.
MPN Research Foundation.What is polycythemia vera (PV)?
Cancer Connect.Ask the experts about COVID-19 and myeloproliferative neoplasms (MF-PV-ET).
American Society of Hematology.COVID-19 and myeloproliferative neoplasms: Frequently asked questions.
Vaccines (Basel).
2021;35(2):485-493. doi:10.1038/s41375-020-01107-y
